Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 35Prostatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 24Lung Neoplasms 15Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Carcinoma, Ovarian Epithelial 7Adenocarcinoma of Lung 7Inflammatory Breast Neoplasms 6Fallopian Tube Neoplasms 6Breast Neoplasms, Male 6Stomach Neoplasms 4Head and Neck Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Tongue Neoplasms 3Pain 3Neoplasm Metastasis 3Adenocarcinoma, Bronchiolo-Alveolar 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Pleural Effusion, Malignant 2Oropharyngeal Neoplasms 2Neoplasms 2Lymphoid Interstitial Pneumonia 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Brenner Tumor 2

Interventions

Radiotherapy 2lerisetron 1Granisetron 1Docetaxel 1Analgesia 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Nausea × Docetaxel × Clear all
NCT00978549 2013-08-07

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

National Cancer Institute (NCI)

Phase 3 Completed
320 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Nausea, Pain, Stomach Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡